Blog
Is 7-OH the Same as Kratom?
A direct answer to the most important distinction: natural kratom leaf is not the same risk category as concentrated 7-OH products.
By The Truth About 7-OH · Updated
Direct answer
No: 7-OH is a compound related to kratom, not a synonym for a leaf product. FDA explicitly distinguished concentrated 7-OH from natural leaf in its July 2025 announcement. FDA July 2025 scheduling recommendation
Start with the substance, then the formulation
A plant name, an alkaloid name, and a product name describe different things. Kratom is the plant; mitragynine and 7-OH are related alkaloids; a tablet or extract is a formulation. Knowing one does not fully specify the others.
Laboratory work shows that mitragynine and 7-OH differ in opioid-receptor activity. That is another reason not to treat equal amounts as equivalent. Kruegel et al. 2016 receptor study
Read the denominator before comparing numbers
FDA's assessment describes natural leaf's 7-OH as less than 2% of total alkaloid content. That is not "2% of the leaf," and it is not a milligram amount per serving. FDA 7-OH scientific assessment
For any label comparison, ask what is being measured: whole-product weight, total alkaloids, concentration in liquid, or amount in a serving. Numbers with different denominators do not form a valid comparison.
This article does not provide a conversion from leaf to tablets or a safe exposure threshold.
What does October 2026 change?
FDA's updated public-health page describes a revised threshold approach for 7-OH and MGPI intended to distinguish enhanced formulations from botanical profiles. FDA October 2026 7-OH update
The October 14 Federal Register document is a notice of intent. An order may follow on or after November 13, 2026; this notice is not itself an effective 7-OH ban. Existing MGPI controls are a separate part of the record. DEA October 14, 2026 notice of intent
Do not interpret a proposed legal threshold as a medical recommendation.
Better questions than "is it kratom?"
Ask what ingredients are listed, how the amount is expressed, whether the product is enhanced, and whether you can show the package to a clinician. If you do not know the contents, keep that uncertainty visible.
FDA warns that concentrated 7-OH products may be inaccurately labeled or marketed as kratom. A package name alone cannot settle the distinction. FDA July 2025 scheduling recommendation
Where to go next
Read What Is 7-OH? for the compound, Science and Evidence for study limitations, and the Regulatory Tracker for dated legal context.